Alveolar Cleft Grafting Using Two Different Alloplastic Grafts
- Conditions
- Alveolar Cleft Grafting
- Interventions
- Registration Number
- NCT03016793
- Lead Sponsor
- Cairo University
- Brief Summary
P-patients with unilateral alveolar clefts I-purabone with -β-tricalcium phosphate graft C-β-tricalcium phosphate graft alone O-clinical out come Outcome name Measurement device Measurement unit Esthetic satisfaction (Primary outcome) Numerical rating scale(NRS) Number 0-10
Radiographic outcome:
Outcome name Measurment Device Measurment unite Bone volume
(Secondary out come) (CBCT)machine Cranex 3D Sordex Cubic millimeter Bone Density
(Secondary Outcome) (CBCT)machine Cranex 3D Sordex Hounsfield Unite Research Question Would purabone addition to β-tricalcium phosphate be more effective and esthetically satisfying than tricalcium phosphate alone in alveolar cleft grafting?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Patients with unilateral alveolar cleft indicated for bone grafting.
- Patients age range between 8-12years.
- Patients with any systemic diseases that can affect normal bone and/or wound healing.
- Patients with bilateral alveolar clefts.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description puerarin and β- tricalcium phosphate β- tricalcium phosphate purabone (puerarin) is an osteoinductive bone grafts used to augment bone healing. β- tricalcium phosphate is an osteoconductive bone graft used to augment bone healing β- tricalcium phosphate alone β- tricalcium phosphate alone β- tricalcium phosphate is an osteoconductive bone graft used to augment bone healing puerarin and β- tricalcium phosphate Puerarin purabone (puerarin) is an osteoinductive bone grafts used to augment bone healing. β- tricalcium phosphate is an osteoconductive bone graft used to augment bone healing
- Primary Outcome Measures
Name Time Method Esthetic satisfaction 6 months outcome measured by numerical scale from 1-10
- Secondary Outcome Measures
Name Time Method bone density 6 months Outcome measured by cone beam computed tomography (CBCT)
bone volume 6 months outcome measured by cone beam computed tomography ( CBCT)
Trial Locations
- Locations (1)
Mohamad hamed Maklad
🇪🇬Suez, Egypt